These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 21681522)
1. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Northcott PA; Hielscher T; Dubuc A; Mack S; Shih D; Remke M; Al-Halabi H; Albrecht S; Jabado N; Eberhart CG; Grajkowska W; Weiss WA; Clifford SC; Bouffet E; Rutka JT; Korshunov A; Pfister S; Taylor MD Acta Neuropathol; 2011 Aug; 122(2):231-40. PubMed ID: 21681522 [TBL] [Abstract][Full Text] [Related]
2. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822 [TBL] [Abstract][Full Text] [Related]
3. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma. Korshunov A; Remke M; Kool M; Hielscher T; Northcott PA; Williamson D; Pfaff E; Witt H; Jones DT; Ryzhova M; Cho YJ; Wittmann A; Benner A; Weiss WA; von Deimling A; Scheurlen W; Kulozik AE; Clifford SC; Peter Collins V; Westermann F; Taylor MD; Lichter P; Pfister SM Acta Neuropathol; 2012 Apr; 123(4):515-27. PubMed ID: 22160402 [TBL] [Abstract][Full Text] [Related]
4. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Zhukova N; Ramaswamy V; Remke M; Pfaff E; Shih DJ; Martin DC; Castelo-Branco P; Baskin B; Ray PN; Bouffet E; von Bueren AO; Jones DT; Northcott PA; Kool M; Sturm D; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognar L; Klekner A; Cho BK; Kim SK; Wang KC; Eberhart CG; Fevre-Montange M; Fouladi M; French PJ; Kros M; Grajkowska WA; Gupta N; Weiss WA; Hauser P; Jabado N; Jouvet A; Jung S; Kumabe T; Lach B; Leonard JR; Rubin JB; Liau LM; Massimi L; Pollack IF; Shin Ra Y; Van Meir EG; Zitterbart K; Schüller U; Hill RM; Lindsey JC; Schwalbe EC; Bailey S; Ellison DW; Hawkins C; Malkin D; Clifford SC; Korshunov A; Pfister S; Taylor MD; Tabori U J Clin Oncol; 2013 Aug; 31(23):2927-35. PubMed ID: 23835706 [TBL] [Abstract][Full Text] [Related]
6. Rapid diagnosis of medulloblastoma molecular subgroups. Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292 [TBL] [Abstract][Full Text] [Related]
7. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Grammel D; Warmuth-Metz M; von Bueren AO; Kool M; Pietsch T; Kretzschmar HA; Rowitch DH; Rutkowski S; Pfister SM; Schüller U Acta Neuropathol; 2012 Apr; 123(4):601-14. PubMed ID: 22349907 [TBL] [Abstract][Full Text] [Related]
8. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes. Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348 [TBL] [Abstract][Full Text] [Related]
9. Subgroup and subtype-specific outcomes in adult medulloblastoma. Coltin H; Sundaresan L; Smith KS; Skowron P; Massimi L; Eberhart CG; Schreck KC; Gupta N; Weiss WA; Tirapelli D; Carlotti C; Li KKW; Ryzhova M; Golanov A; Zheludkova O; Absalyamova O; Okonechnikov K; Stichel D; von Deimling A; Giannini C; Raskin S; Van Meir EG; Chan JA; Fults D; Chambless LB; Kim SK; Vasiljevic A; Faure-Conter C; Vibhakar R; Jung S; Leary S; Mora J; McLendon RE; Pollack IF; Hauser P; Grajkowska WA; Rubin JB; van Veelen MC; French PJ; Kros JM; Liau LM; Pfister SM; Kool M; Kijima N; Taylor MD; Packer RJ; Northcott PA; Korshunov A; Ramaswamy V Acta Neuropathol; 2021 Nov; 142(5):859-871. PubMed ID: 34409497 [TBL] [Abstract][Full Text] [Related]
10. Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles. Korshunov A; Sahm F; Okonechnikov K; Ryzhova M; Stichel D; Schrimpf D; Casalini B; Sievers P; Meyer J; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; Kool M; von Deimling A Acta Neuropathol; 2019 Jun; 137(6):1003-1015. PubMed ID: 30826918 [TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586 [TBL] [Abstract][Full Text] [Related]
12. Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas. Kunder R; Jalali R; Sridhar E; Moiyadi A; Goel N; Goel A; Gupta T; Krishnatry R; Kannan S; Kurkure P; Deopujari C; Shetty P; Biyani N; Korshunov A; Pfister SM; Northcott PA; Shirsat NV Neuro Oncol; 2013 Dec; 15(12):1644-51. PubMed ID: 24203893 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas. Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698 [TBL] [Abstract][Full Text] [Related]
14. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma. Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541 [TBL] [Abstract][Full Text] [Related]
15. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas. Menyhárt O; Győrffy B Ann Clin Transl Neurol; 2019 May; 6(5):990-1005. PubMed ID: 31139698 [TBL] [Abstract][Full Text] [Related]
16. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry. Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267 [TBL] [Abstract][Full Text] [Related]
17. Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. McManamy CS; Pears J; Weston CL; Hanzely Z; Ironside JW; Taylor RE; Grundy RG; Clifford SC; Ellison DW; Brain Pathol; 2007 Apr; 17(2):151-64. PubMed ID: 17388946 [TBL] [Abstract][Full Text] [Related]
18. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma. Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958 [TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation. Cambruzzi E Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]